#TheRightDose

Medical CommunityMBC PatientsPatient AdvocatesDiagnosis and TreatmentLong Term Adverse EffectsObstacles to Better OutcomesPatient Reported Outcomes and Out of the Box Treatment OptionsLiving with MBCEssential Knowledge

Dec 7

Written By Our MBClife

Today we learn more about the Patient-Centered Dosing Initiative (“The Right Dose “) with MBC advocate and author, Anne Loeser and Dr. Aditya Bardia, Attending Physician at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School. Usually when metastatic breast cancer patients begin new treatment, they are treated with the highest possible dosage, also known as the Maximum Tolerated Dose (MTD) that causes the most challenging side effects. Given we, those living with MBC, will be in treatment for the rest of our lives, The Right Dose Initiative aims to dismantle this paradigm for MBC patients.

This conversation was the last interview our friend and co-host Chawnte Randall was able to do before she died on November 12. She was a member of The Right Dose Initiative working group along with the many other MBC organizations and foundations to which she volunteered her time and expertise.

SOCIAL/HASHTAGS
#therightdose
The Right Dose X Instagram Facebook
Dr. Aditya Barida X

THE RIGHT DOSE, PRECISION MEDICINE, DR. BARDIA
The Right Dose: Criteria to Consider
Metastatic Trial Talk: Giving The Right Dose of Drugs for MBC - The Patient-Centerd Dosing Initiative and Project Optimus
Cancer Today Magazine: The Right Dose
Dr. Bardia’s Publications